paclitaxel has been researched along with Leukemia, Myeloid, Acute in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (10.00) | 18.7374 |
| 1990's | 7 (23.33) | 18.2507 |
| 2000's | 8 (26.67) | 29.6817 |
| 2010's | 5 (16.67) | 24.3611 |
| 2020's | 7 (23.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Gallucci, JC; Kinghorn, AD; Li, X; Ren, Y; Yu, J | 1 |
| Okines, A; Turner, N | 1 |
| Geyer, CE; Loibl, S; Sikov, WM | 1 |
| Aissouni, Y; Balayssac, D; Busserolles, J; Chapuy, E; Collin, A; Condé, S; Dalbos, C; Dumontet, C; Martin, PY; Mattévi, C; Richard, D; Selvy, M | 1 |
| Bai, ZW; Liu, ZF; Pang, RL; Shi, ZY; Wu, MQ; Yao, YB; Zhao, WH; Zhou, BW | 1 |
| He, C; Jiang, L; Meng, Y; Tong, T; Wang, K; Wang, L; Wu, J; Xu, X; You, X; Yu, Y; Zhang, W; Zhao, M | 1 |
| Abe, R; Kawamura, N; Kawanishi, M; Murakami, M; Nagatsuji, M; Okajima, S; Suruga, M; Tokuyama, O; Yamane, T | 1 |
| Kim, D; Kim, M; Kim, R; Kim, S; Kim, Y; Koh, Y; Ku, J; Kwon, NH; Lee, K; Lee, N; Song, S; Yoon, SS | 1 |
| Iida, K; Ishibashi, T; Ishikawa, M; Katagiri, A; Katagiri, H; Miyazaki, K; Nakayama, K; Nakayama, N; Rahman, M; Rahman, MT | 1 |
| Altmann, KH; Ambati, S; Calvo-Vidal, MN; Cerchietti, L; Díaz, JF; Fang, W; Jordi, M; Kahn, A; Moore, MAS; Pera, B | 1 |
| Chen, YJ; Huang, HM; Huang, YW; Lee, YL; Liou, JP; Liu, HE; Wang, CC | 1 |
| Asbell, SO; Bae, K; Kerlin, KJ; Michalski, JM; Pienta, KJ; Rajan, R; Rosenthal, SA; Sandler, HM; Sobczak, ML | 1 |
| Irie, T; Mori, A; Morioka, M; Saito, M; Tanaka, M | 1 |
| Foretová, L; Fridrichová, P; Laco, J; Melichar, B; Papajík, T; Simkovič, M | 1 |
| Boehlke, I; Bokemeyer, C; Hartmann, JT; Kanz, L; Kollmannsberger, C; Kuczyk, M; Metzner, B; Schleicher, J; Schleucher, N; Wierecky, J | 1 |
| Berry, DA; Budman, DR; Cirrincione, C; Citron, ML; Henderson, IC; Hudis, CA; Muss, HB; Norton, L; Winer, EP | 1 |
| Han, K; Kim, HJ; Kim, M; Kim, SY; Kim, Y; Lee, SY; Lim, J; Park, IY | 1 |
| Ahmed, T; Darzynkiewicz, Z; Feldman, EJ; Halicka, HD; Lederman, CA; Li, X; Romero, MB; Seiter, K; Traganos, F | 1 |
| Bhalla, K; Bullock, G; Huang, Y; Ibrado, AM; Mahoney, ME; Ponnathpur, V; Ray, S; Tang, C | 1 |
| Curtis, JE; McCulloch, EA; Minden, MD; Minkin, S | 1 |
| Andreeff, M; Estey, EH; Kantarjian, H; Keating, M; Munker, R; O'Brien, S | 1 |
| Hu, ZB; McCulloch, EA; Minden, MD | 1 |
| Craig, RW; Eastman, A; Townsend, KJ; Traupman, MA; Trusty, JL | 1 |
| Hu, ZB; McCulloch, EA; Minden, MD; Stahl, J | 1 |
| Larsson, BS; Mårs, U; Masquelier, M; Pålsson, M; Peterson, CO; Vitols, S | 1 |
| Fowler, JM; Greer, BE; Horowitz, IR; McGuire, WP; Rodriguez, M; Rose, PG; Waggoner, S | 1 |
| Baker, JR; Donehower, RC; Gralla, RJ; Leyland-Jones, B; Ohnuma, T; Trump, DL; Van Echo, DA; Von Hoff, DD; Weiss, RB; Wiernik, PH | 1 |
| Boitnott, JK; Donehower, RC; Hruban, RH; Yardley, JH | 1 |
| Allison, DC; Donehower, RC; Roberts, JR; Robertson, J; Rowinsky, EK | 1 |
| Donehower, RC; Jones, RJ; Rowinsky, EK; Tucker, RW | 1 |
5 trial(s) available for paclitaxel and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Phase III multi-institutional trial of adjuvant chemotherapy with paclitaxel, estramustine, and oral etoposide combined with long-term androgen suppression therapy and radiotherapy versus long-term androgen suppression plus radiotherapy alone for high-ris
Topics: Adult; Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Drug Administration Schedule; Estramustine; Etoposide; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Paclitaxel; Prostatic Neoplasms; Thromboembolism | 2009 |
Toxicity of older and younger patients treated with adjuvant chemotherapy for node-positive breast cancer: the Cancer and Leukemia Group B Experience.
Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Female; Humans; Leukemia, Myeloid, Acute; Lymphatic Metastasis; Middle Aged; Myelodysplastic Syndromes; Neoplasms, Second Primary; Paclitaxel | 2007 |
Evaluation of in vivo induction of apoptosis in patients with acute leukemia treated on a phase I study of paclitaxel.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Apoptosis; Blast Crisis; DNA Damage; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Middle Aged; Paclitaxel; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1995 |
Phase I study of taxol in refractory acute myelogenous leukemias using a weekly schedule.
Topics: Adult; Aged; Drug Administration Schedule; Humans; Leukemia, Myeloid, Acute; Middle Aged; Paclitaxel | 1998 |
Phase I study of paclitaxel, carboplatin, and increasing days of prolonged oral etoposide in ovarian, peritoneal, and tubal carcinoma: a gynecologic oncology group study.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Etoposide; Fallopian Tube Neoplasms; Female; Humans; Leukemia, Myeloid, Acute; Maximum Tolerated Dose; Middle Aged; Neutropenia; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Thrombocytopenia | 2000 |
25 other study(ies) available for paclitaxel and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Crystal Structures and Human Leukemia Cell Apoptosis Inducible Activities of Parthenolide Analogues Isolated from Piptocoma rufescens.
Topics: Apoptosis; Asteraceae; Caspase 3; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Humans; Leukemia, Myeloid, Acute; NF-kappa B; Sesquiterpenes | 2018 |
Risk of MDS/AML with the addition of neoadjuvant carboplatin to standard chemotherapy for triple-negative breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Female; Humans; Leukemia, Myeloid, Acute; Neoadjuvant Therapy; Paclitaxel; Treatment Outcome; Triple Negative Breast Neoplasms | 2022 |
Reply to the Letter to the Editor 'Risk of MDS/AML with the addition of neoadjuvant carboplatin to standard chemotherapy for triple-negative breast cancer' by A. Okines and N. Turner.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Humans; Leukemia, Myeloid, Acute; Neoadjuvant Therapy; Paclitaxel; Triple Negative Breast Neoplasms | 2022 |
Analgesic and preventive effects of donepezil in animal models of chemotherapy-induced peripheral neuropathy: Involvement of spinal muscarinic acetylcholine M2 receptors.
Topics: Acetylcholine; Analgesics; Animals; Antineoplastic Agents; Cholinesterase Inhibitors; Donepezil; Leukemia, Myeloid, Acute; Models, Animal; Paclitaxel; Peripheral Nervous System Diseases; Rats; Receptor, Muscarinic M2; Receptors, Muscarinic | 2022 |
[Effects of Paclitaxel and Quizartinib Alone and in Combination on AML Cell Line MV4-11 and Its STAT5 Signal Pathway].
Topics: Apoptosis; Benzothiazoles; Cell Line, Tumor; fms-Like Tyrosine Kinase 3; Humans; Leukemia, Myeloid, Acute; Paclitaxel; Phenylurea Compounds; RNA, Messenger; Signal Transduction; STAT5 Transcription Factor | 2022 |
A Ferroptosis-Inducing and Leukemic Cell-Targeting Drug Nanocarrier Formed by Redox-Responsive Cysteine Polymer for Acute Myeloid Leukemia Therapy.
Topics: Animals; Cysteine; Ferroptosis; Leukemia, Myeloid, Acute; Mice; Oxidation-Reduction; Paclitaxel; Polymers | 2023 |
[A Case of Myelodysplastic Syndrome Developed during Chemotherapy for Postoperative Recurrent Ovarian Cancer That Progressed to Acute Myeloid Leukemia].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Carcinoma, Ovarian Epithelial; Female; Humans; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Ovarian Neoplasms; Paclitaxel; Quality of Life | 2023 |
Single-cell analysis of AIMP2 splice variants informs on drug sensitivity and prognosis in hematologic cancer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alternative Splicing; Cell Line, Tumor; Drug Resistance, Neoplasm; Exons; Female; Gene Expression Regulation, Neoplastic; Hematologic Neoplasms; Humans; Image Processing, Computer-Assisted; In Situ Hybridization, Fluorescence; Leukemia, Myeloid, Acute; Male; Middle Aged; Molecular Targeted Therapy; Nuclear Proteins; Paclitaxel; Prognosis; Single-Cell Analysis; Young Adult | 2020 |
Therapy-related myelodysplastic syndrome and acute myeloid leukemia following chemotherapy (paclitaxel and carboplatin) and radiation therapy in ovarian cancer: a case report.
Topics: Adrenal Gland Neoplasms; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Cerebral Infarction; Chemoradiotherapy; Fatal Outcome; Female; Humans; Leukemia, Myeloid, Acute; Liver Neoplasms; Myelodysplastic Syndromes; Neoplasms, Second Primary; Neoplastic Cells, Circulating; Ovarian Neoplasms; Paclitaxel | 2014 |
High affinity and covalent-binding microtubule stabilizing agents show activity in chemotherapy-resistant acute myeloid leukemia cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Cycle Checkpoints; Cell Proliferation; Daunorubicin; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Synergism; Hematopoietic Stem Cells; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Macrolides; Mice; Microtubules; Neoplastic Stem Cells; Paclitaxel; Time Factors; Tubulin Modulators | 2015 |
MPT0B169, a novel tubulin inhibitor, induces apoptosis in taxol-resistant acute myeloid leukemia cells through mitochondrial dysfunction and Mcl-1 downregulation.
Topics: Apoptosis; Caspase 3; Caspase 9; Cell Line, Tumor; Cytochromes c; Drug Resistance, Neoplasm; Gene Expression Regulation, Leukemic; Gene Knockdown Techniques; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Membrane Potential, Mitochondrial; Mitochondria; Myeloid Cell Leukemia Sequence 1 Protein; Paclitaxel; Sarcosine; Sulfonamides; Tubulin Modulators | 2016 |
[Therapy-related acute myeloid leukemia with 11q23 abnormality due to paclitaxel coexisting with bone marrow metastasis of breast cancer].
Topics: Antineoplastic Agents, Phytogenic; Bone Marrow Neoplasms; Breast Neoplasms; Chromosome Aberrations; Chromosomes, Human, Pair 11; Female; Humans; Leukemia, Myeloid, Acute; Middle Aged; Neoplasms, Second Primary; Paclitaxel | 2009 |
Therapy-related myeloid neoplasms in epithelial ovarian cancer patients carrying BRCA1 mutation: report of two cases.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ovarian Epithelial; Cystadenocarcinoma, Serous; Fatal Outcome; Female; Genes, BRCA1; Heterozygote; Humans; Leukemia, Myeloid, Acute; Middle Aged; Mutation; Neoplasms, Glandular and Epithelial; Neoplasms, Second Primary; Ovarian Neoplasms; Paclitaxel; Platinum | 2012 |
Secondary leukemia after first-line high-dose chemotherapy for patients with advanced germ cell cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials, Phase II as Topic; Etoposide; Follow-Up Studies; Germany; Germinoma; Humans; Ifosfamide; Leukemia, Myeloid, Acute; Male; Mediastinal Neoplasms; Multicenter Studies as Topic; Myelodysplastic Syndromes; Neoplasms, Second Primary; Paclitaxel; Peripheral Blood Stem Cell Transplantation; Testicular Neoplasms; Translocation, Genetic; Transplantation, Autologous | 2005 |
[A case of therapy-related acute myeloid leukemia associated with inv(16)].
Topics: Antimitotic Agents; Antineoplastic Combined Chemotherapy Protocols; Chromosome Inversion; Chromosomes, Human, Pair 16; Cisplatin; Female; Humans; Leukemia, Myeloid, Acute; Middle Aged; Paclitaxel; Taxoids | 2007 |
1-beta-D-arabinofuranosylcytosine-, mitoxantrone-, and paclitaxel-induced apoptosis in HL-60 cells: improved method for detection of internucleosomal DNA fragmentation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cytarabine; DNA Damage; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Administration Schedule; Electrophoresis, Agar Gel; Genome, Human; Humans; Leukemia, Myeloid, Acute; Mitoxantrone; Paclitaxel; Tumor Cells, Cultured | 1994 |
A role for paclitaxel in the combination chemotherapy of acute myeloblastic leukaemia: preclinical cell culture studies.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Cytarabine; Dose-Response Relationship, Drug; Drug Synergism; Female; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Paclitaxel; Tretinoin; Tumor Cells, Cultured | 1996 |
Phosphorylation of BCL-2 after exposure of human leukemic cells to retinoic acid.
Topics: Dimerization; Electrophoresis, Gel, Two-Dimensional; Humans; Immunosorbent Techniques; Leukemia, Myeloid, Acute; Paclitaxel; Phosphoamino Acids; Phosphoric Monoester Hydrolases; Phosphorus Radioisotopes; Phosphorylation; Phosphoserine; Proto-Oncogene Proteins c-bcl-2; Recombinant Proteins; Tretinoin; Tumor Cells, Cultured | 1998 |
Expression of the antiapoptotic MCL1 gene product is regulated by a mitogen activated protein kinase-mediated pathway triggered through microtubule disruption and protein kinase C.
Topics: Calcium-Calmodulin-Dependent Protein Kinases; Cell Death; Cisplatin; Colchicine; Humans; Leukemia, Myeloid, Acute; Microtubules; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Proteins; Paclitaxel; Phosphorylation; Protein Kinase C; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Vinblastine | 1998 |
Regulation of drug sensitivity by ribosomal protein S3a.
Topics: Animals; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line; Cryopreservation; Cytarabine; DNA Replication; DNA, Neoplasm; Doxorubicin; Drug Resistance, Neoplasm; Gene Targeting; Humans; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Chronic; Neoplasm Proteins; Neoplastic Stem Cells; Paclitaxel; Phosphorylation; Phosphoserine; Protein Processing, Post-Translational; Rats; Ribosomal Proteins; Tissue Preservation; Treatment Outcome; Tretinoin | 2000 |
Low density lipoprotein as a carrier of cytostatics in cancer chemotherapy: study of stability of drug-carrier complexes in blood.
Topics: Aged; Aged, 80 and over; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Doxorubicin; Drug Carriers; Female; Humans; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Lipoproteins, LDL; Male; Mice; Mice, Inbred BALB C; Middle Aged; Paclitaxel | 2000 |
Hypersensitivity reactions from taxol.
Topics: Adult; Aged; Alkaloids; Antineoplastic Agents, Phytogenic; Cimetidine; Colonic Neoplasms; Dexamethasone; Drug Administration Schedule; Drug Hypersensitivity; Female; Humans; Hypersensitivity, Immediate; Leukemia, Myeloid, Acute; Male; Melanoma; Middle Aged; Paclitaxel; Premedication | 1990 |
Taxol toxicity. Epithelial necrosis in the gastrointestinal tract associated with polymerized microtubule accumulation and mitotic arrest.
Topics: Adult; Aged; Alkaloids; Antineoplastic Agents, Phytogenic; Digestive System; Epithelium; Female; Germ Cells; Humans; Leukemia, Myeloid, Acute; Male; Microtubules; Middle Aged; Mitosis; Necrosis; Ovarian Neoplasms; Paclitaxel; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Testis | 1989 |
Demonstration of the cell cycle positions of taxol-induced "asters" and "bundles" by sequential measurements of tubulin immunofluorescence, DNA content, and autoradiographic labeling of taxol-sensitive and -resistant cells.
Topics: Alkaloids; Antineoplastic Agents, Phytogenic; Autoradiography; Cell Cycle; Cell Line; DNA; Drug Resistance; Fluorescent Antibody Technique; Humans; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Microscopy, Electron; Microtubules; Mitosis; Paclitaxel; Thymidine; Tubulin | 1989 |
Microtubule changes and cytotoxicity in leukemic cell lines treated with taxol.
Topics: Alkaloids; Cell Line; Cell Survival; Flow Cytometry; Fluorescent Antibody Technique; Humans; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Microscopy, Electron; Microtubules; Paclitaxel | 1988 |